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Abstract 24 25
Sequencing studies have highlighted candidate sets of genes involved in 26 schizophrenia, including activity-regulated cytoskeleton-associated protein (ARC) 27
and N-methyl-d-aspartate receptor (NMDAR) complexes. Two genes, SETD1A and 28 RBM12, have also been associated with robust statistical evidence. Larger samples 29 and novel methods for identifying disease-associated missense variants are needed to 30 reveal novel genes and biological mechanisms associated with schizophrenia. We 31 sequenced 187 genes, selected for prior evidence of association with schizophrenia, in 32 a new dataset of 5,207 cases and 4,991 controls. Included were members of ARC and 33 NMDAR post-synaptic protein complexes, as well as voltage-gated sodium and 34 calcium channels. We observed a significant case excess of rare (<0.1% in frequency) 35 loss-of-function (LoF) mutations across all 187 genes (OR = 1.36; P corrected = 0.0072) 36 but no individual gene was associated with schizophrenia after correcting for multiple 37 testing. We found novel evidence that LoF and missense variants at paralog conserved 38 sites were enriched in sodium channels (OR = 1.26; P = 0.0035). Meta-analysis of our 39 new data with published sequencing data (11,319 cases, 15,854 controls and 1,136 40 trios) supported and refined this association to sodium channel alpha subunits (P = 41 0.0029). Meta-analysis also confirmed association between schizophrenia and rare 42 variants in ARC (P = 4.0 x 10 -4 ) and NMDAR (P = 1.7 x 10 -5 ) synaptic genes. No 43 association was found between rare variants in calcium channels and schizophrenia. 44
In one of the largest sequencing studies of schizophrenia to date, we provide 45 novel evidence that multiple voltage-gated sodium channels are involved in 46 schizophrenia pathogenesis, and increase the evidence for association between rare 47 calcium channels), we exploited this approach to analyse missense variants that are 122 more likely to have an adverse effect on protein function [20] . 123
Finally, to maximise power, we combined the new sequencing data with 124 independent, published schizophrenia case-control (Swedish [7] and UK10K [11] 125 datasets) and trio exome-sequencing data (see methods), yielding a combined analysis 126 of RCVs in a total of 11,319 cases, 15,854 controls and 1,136 trios. 127
128
Results 129
130

Mutation burden 131
In the targeted sequence sample, we performed six primary tests of mutation burden 132 across all 187 targeted genes: LoF, nonsynonymous damaging and nonsynonymous 133 variants, each under two allele frequency thresholds; < 0.1% and singletons. A 134 significant (P corrected < 0.05) excess of LoF mutations (< 0.1% in frequency) was 135 observed in cases (Table 1) , who had a mean excess of 0.013 LoF mutations per 136 person across the 187 targeted genes (Supplementary Table S2 ). There was no 137 significant difference in the rate of any other class of allele (Table 1) . Although not 138 part of our primary analysis, we note no difference between cases and controls in the 139 rate of synonymous mutations (frequency <0.1%) (OR (95% CI) = 1.02 (0.94-1.08); P 140 = 1), suggesting the enrichment of LoF mutations in cases is unlikely to be due to 141 technical artefacts. Targeted sequencing sample includes data from 5,207 cases and 4,991 controls. Meta-analysis includes data from 11,319 cases and 15,854 148 controls. Rates correspond to the average number of mutations per case/control. P values are 2-sided, odds ratios (OR) and 95% confidence 149 intervals (CI) were generated from logistic regression models. In the targeted sequencing sample, P values that survive Bonferroni correction for 150 multiple testing (6 tests) are in bold. LoF = loss of function, NSD = nonsynonymous damaging, NS = nonsynonymous, mut. = mutation, MAF = 151 minor allele frequency. Meta-analysis with two previously published case-control exome sequencing 153 datasets (Sweden and UK10K, see methods for detail) strengthened the evidence for 154 an increase in LoF mutations (frequency <0.1%) in cases (Table 1 and Supplementary  155   Table S3 ). The additional support came entirely from the Swedish rather than the 156 UK10K dataset (Sweden OR (95% CI) = 1.27 (1.08-1.51; P = 4.8 x 10 -3 ; UK10K OR 157 (95% CI) = 0.95 (0.74-1.2); P = 0.66). The results contributing to the meta-analysis 158 are presented in Supplementary Table S3 . 159
We partitioned the 187 genes into those intolerant of LoF mutation (pLi scores 160 > 0.9 in nonpsych-ExAC data [16] ) and those that are not intolerant (pLi ≤ 0.9). Meta-161 analysis of the case-control data showed association between schizophrenia and rare 162 (frequency <0.1%) LoF mutations was driven by LoF intolerant genes (106 genes 163 with pLi > 0.9: OR (95% CI) = 1.63 (1.33 -2.0); P = 2.9 x 10 -6
. 81 genes with pLi ≤ 164 0.9: OR (95% CI) = 1.09 (0.95 -1.24); P = 0.21). The difference in effect size 165 between pLi and non-pLi burden tests was significant (Z-test P = 0.0006). 166
167
Gene set analysis 168
In the targeted sequencing analysis, as only LoF mutations with a frequency <0.1% 169 were significantly enriched in cases after correcting for multiple testing, we tested this 170 class of mutation for gene set enrichment. 171
ARC and NMDAR:
In the targeted sequencing sample, cases had a higher rate 172 of LoF mutations (frequency <0.1%) in ARC and NMDAR sets (Fig 1) . When meta-173 analysed with published case-control datasets, we found strong evidence that LoF 174 mutations in NMDAR genes were associated with schizophrenia (P = 1.6 x 10 -4
, Fig 1  175 and Supplementary Table S4 ), but weaker evidence for association with ARC genes 176
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To summarize the current status of RCVs in the above gene sets, we combined 178 the case-control meta-analysis data with the de novo mutation data, selecting the class 179 of de novos reported to be most strongly enriched in these gene sets (nonsynonymous 180 de novo mutations in ARC and LoF de novo mutations NMDAR) in the previous 181 work [9] . In the trio data, nonsynonymous and LoF de novo mutations were 182 associated with ARC (P = 0.0015) and NMDAR (P = 0.014), respectively. 183
Combining the de novo enrichment results with the case-control meta-analysis results 184 (LoF, frequency < 0.1%), both ARC (P = 4.0 x 10 -4 ) and NMDAR (P = 1.7 x 10 -5 ) 185
were associated with schizophrenia (Table 2) . 186
The ARC and NMDAR complexes share 9 overlapping genes: when excluded 187 from the analysis, we observed independent evidence for association with both gene 188 sets (case-control-de novo meta-analysis: ARC P = 9.4 x 10 -4 ; NMDAR P = 7.4 x 10 Table S5 ). Enrichment of rare (frequency 208 <0.1%) paralog conserved missense and LoF variants was also supported in the full 209 case-control meta-analysis (OR (95% CI) = 1.18 (1.07 -1.31); P = 0.0014, Fig 2,  210 Supplementary Table S5), and was robust to exclusion of LoF mutations from the 211 analysis (OR (95% CI) = 1.16 (1.04 -1.29); P = 0.007). The effect size for rare 212 (frequency <0.1%) paralog conserved missense and LoF variants was significantly 213 different to that for paralog non-conserved missense variants (Z-test P = 0.0018), 214 indeed there was no enrichment for missense variants at paralog non-conserved sites 215 (case-control meta-analysis P = 0.44, Fig 2, Supplementary Table S5 ). 216
We divided the voltage-gated sodium channel set into alpha (10 genes) and 217 beta (4 genes) subunits, testing these separately; only the alpha subunits were 218 significantly enriched for rare (frequency <0.1%) paralog conserved missense and 219 dataset given the inability to phase very low frequency variation. In addition to 271 previous genetic support in schizophrenia, we note sodium channels have high 272 biological plausibility given that mutations in this gene set have been associated with 273 other neurodevelopmental disorders, including some forms of epilepsy and 274 developmental delay [20] [21] [22] . In the current study, no single sodium channel gene was 275 significantly associated with schizophrenia (after correction for multiple testing), with 276 the most significant gene being SCN7A (P uncorrected = 0.0012). 277
The sodium channel set contains 14 genes, 10 encoding alpha subunits 278 involved in generating action potentials [21] , and 4 beta subunits which, in 279 association with alpha subunits, modulate their gating and cellular excitability [22] . In 280 the present study, the evidence for association derives from mutations in alpha 281 subunits, although the absence of signal in beta-subunits might simply reflect low 282 power (there are fewer beta-subunits, of which paralog conservation scores are only 283 available for SCN2B and SCN4B, whereas paralog conservation scores are available 284 for all 10 alpha subunits). 285
Despite the increased sample size, we did not observe any single-gene 286 association that remained statistically significant after correction for multiple testing. 287 However, our gene set enrichment results suggest that significant single gene 288 associations will be discovered when larger samples are combined with more 289 effective methods for identifying disease-associated missense variation. 290 A limitation of our study was the exclusion of indel mutations (see methods) 291 from the targeted sequencing. Also, given the restrictions posed by targeted 292 sequencing, we were unable to test some of the much larger gene sets that have been 293 implicated by common and rare variation in schizophrenia, for example targets of 294 1 4
In conclusion, we conducted one of the largest sequencing studies of 296 schizophrenia to date, which targeted the protein coding regions of 187 putative 297 schizophrenia risk genes. We found a significant excess of LoF alleles in cases among 298 all 187 targeted genes. By leveraging information from paralog conservation, we 299 provide novel evidence that multiple voltage-gated sodium channels are involved in 300 schizophrenia pathogenesis. We provide further support for association between 301
RCVs in ARC and NMDAR post-synaptic protein complexes and schizophrenia. 302
Larger samples are required to identify the specific genes and variants driving these 303 gene set associations. QC was 158X and 160X for wave 1, and 154X and 145X for wave 2, respectively 345 (density plots of sequence coverage in Supplementary Material Fig S1) . Both cases 346
and controls had at least 95% of target bases covered at ≥
10X. 347 348
Gene-selection 349
We sequenced the coding regions of genes belonging to the following gene sets: ARC 350 (n=28) [9] , NMDAR (n=61) [9] , voltage-gated calcium channels (n=26) [15] and 351 voltage-gated sodium channels (n=14) [18] . We sequenced an additional 58 genes, 352 selected for having two or more supportive lines of evidence for association with 353 schizophrenia (full criteria for gene-selection described in Supplementary Material). 354
A list of all 187 sequenced genes, and the rationale for selection is presented in 355 Supplementary Table S1 . 356
357
Data processing and quality control 358
Sequence data were independently processed for each Ion Torrent wave according to 359 GATK best practice guidelines [37, 38] . Reads were aligned to the human g1k (v37) 360 reference genome using bwa [39] . Variants were called using GATK haplotype caller 361 (v3.4) and filtered using the GATK Variant Quality Score Recalibration (VQSR) tool. 362
Sample level QC: Individuals were excluded if they were more than 3 standard 363 deviations from their sequencing wave's mean for: proportion of variants in dbSNP; 364 number of alternative alleles; number of singletons; total number of synonymous 365 mutations; total number of nonsynonymous mutations. When available, SNP 366 genotyping array data were used to assess sequencing-array genotype concordance 367 (array genotypes used as truth set) and to identify duplicate/first degree relatives. SNP 368 genotyping array data from 3 chips (Illumina OmniExpress, Illumina ExomeChip,
Immunochip) were available for 96% (5,508/5,724) of cases and 72% (4,149/5,769) 370 of controls. Samples were excluded if they had a genotype concordance < 0.9 or if 371 they were found to be one member of a duplicate (kinship coefficient > 0.354) or 372 first-degree relative (kinship coefficient > 0.177) pair (identified using the KING 373 toolset [40] in the Bioconductor package SNPRelate). For samples not previously 374 genotyped using SNP arrays, we used Ion Torrent sequence data to identify and 375 exclude duplicate samples. 376
Principal component analysis (PCA) was used to identify and exclude cases 377 and controls with non-European ancestry. We performed PCA in the 1000 genomes 378 project data (phase 3), using variants found in both targeted sequence data and 1000 379 genomes data, and projected our targeted sequence samples onto these PCs using 380
EIGENSOFT smartPCA [41] . Targeted sequence samples were excluded if PCs 1 and 381 2 were more than 3 standard deviations from the mean of PCs from European 1000 382 genome samples (Supplementary Fig S2) . Post sample QC, 5,207 cases and 4,991 383 controls from the targeted sequence sample were retained for analysis. 384
Variant level QC: Variant sites within each targeted Ion Torrent sequencing 385
wave were excluded if they failed Hardy-Weinberg equilibrium exact tests (χ 2 P < 386 10 −8 ), GATK VQSR filters, had > 20% missingness, or contained an indel (sequence 387 data produced by Ion Torrent instruments has low indel specificity [42] ). For targeted 388 sequencing data, individual genotypes were set to missing if they had a depth (DP) < 389 20, genotype quality (GQ) < 80, allele-balance (AB) < 0.9 for non-reference 390 homozygous genotypes or an AB < 0.2 or > 0.8 for heterozygous genotypes. For 391 analysis of previously published exome sequencing data, we applied filters which 392 more closely matched those described in their original publications (DP <=10, GQ < 393 30, AB < 0.9 for non-reference homozygous genotypes, AB < 0.2 or > 0.8 for To annotate sites with their paralog conservation scores, we used para_zscores 416 downloaded from https://zenodo.org/record/817898. In our paralog conserved 417 analysis, we followed the publication describing this metric [20] by testing the burden 418 of all LoF alleles and missense alleles at sites annotated as having a para_zscore > 0. (implemented in R). As gene mutation rates for in-frame indels are not provided in 448
[46], we adopted the method used by the Deciphering Developmental Disorders Study 449
[47], which scaled frameshift mutation rates by the ratio of in-frame to frameshift 450 mutations reported to occur in genome-wide regions under weak negative selection 451 (ratio 1:9) [47] . To estimate the expected number of LoF de novo mutations and 452 missense de novo mutations at paralog conserved sites in sodium channel alpha 453 subunits, we used the mutation rates provided in [20] . 454 455 Meta-analysis: Coefficients and standard errors from independently analysed case-456 control (targeted, UK10K and Swedish) regression tests were meta-analysed as fixed 457 effects using the inverse-variance method (implemented in R using the rma.uni() 458 function as part of the metafor package). To obtain a single enrichment statistic for 459 meta-analysed case-control and de novo tests, we followed the method described in 460
[11], which combined a 1-tail case-control P value with the de novo Poisson test P 461 value using Fisher's combined method. For our combined case- 
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